HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

As theranostic radiopharmaceuticals gain prevalence, companies must overcome associated regulatory, manufacturing and ...

For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have been taking oral supplements of biotin, which are marketed to consumers for ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

A cohort study examines whether the use of common medications was associated with worse outcomes in patients with lung cancer taking immunotherapy.

India has about 2.5 million people living with cancer and around 100 million people with rare diseases, many of whom require medicines that fall outside insurance coverage and price control ...

Exploring new methodologies in cancer treatment, industry experts emphasize the importance of region-specific strategies and innovations in India’s oncology sector amid rising challenges in care ...